EUVIMEDEUVIMED entdecken
Crossref

Safety and efficacy of rectal indomethacin for prevention of post‐endoscopic retrograde cholangiopancreatography pancreatitis in pediatric patients

Mary C Camacho iD, Emma Blythe, B Joseph Elmunzer, Elaine Odiase, Devika Gandhi, Christopher Fritzen, Reuven Zev Cohen, Cary Sauer, Field F Willingham iD

Journal of Pediatric Gastroenterology and Nutrition · 2026

DOI: 10.1002/jpn3.70427 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2026. Verfasst von Mary C Camacho und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Indomethacin, Cholangiopancreatography, Endoscopic Retrograde, Pancreatitis, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Department of Medicine at Emory University School of Medicine, Health Services Research Center at Emory University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Peri‐procedural rectal indomethacin was shown to decrease the incidence of post‐endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) in adults undergoing ERCP. This practice was generalized to pediatric populations, despite an absence of data on safety or efficacy. This study evaluated the safety and efficacy of rectal indomethacin in pediatric patients undergoing ERCP.

Methods

We conducted a retrospective, cohort study of pediatric patients undergoing ERCP (single‐endoscopist) at two tertiary academic hospitals from November 2009 to August 2024. Safety outcomes included bleeding and acute kidney injury (AKI). The efficacy outcome was incidence of PEP with and without indomethacin at 100 mg > 30 kg and 50 mg < 30 kg. Descriptive statistics, univariate analysis, and binary logistic regression adjusting for 18 covariates were performed.

Results

A total of 906 ERCPs were performed in 448 patients. Indomethacin was administered in 757 (83.6%) procedures and not in 148 (16.3%). Bleeding occurred in 3.2% versus 3.4% ( p = 0.90), and AKI in 1.1% versus 0.7% ( p = 0.67). PEP incidence was 3.0% with indomethacin versus 9.5% without ( p < 0.05). On multivariate analysis, indomethacin significantly reduced PEP (odds ratio [OR] = 0.28, 95% confidence interval [CI] [0.11–0.71], p < 0.05; absolute risk reductions [ARR] = 6.5%; number needed to treat [NNT] = 16) without increasing bleeding or AKI. Findings were similar in subgroup analysis of index ERCPs with no increased odds of bleeding or AKI and significantly lower odds of PEP (OR = 0.16, 95%CI[0.05–0.53], p < 0.05; ARR = 12.7%; NNT = 8).

Conclusions

The use of peri‐procedural rectal indomethacin was safe and effective, with no increased bleeding or AKI and a greater than threefold reduction in PEP in pediatric patients. These findings support the use of indomethacin prophylaxis in pediatric patients at 100 mg > 30 kg and 50 mg < 30 kg.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndomethacinCholangiopancreatography, Endoscopic RetrogradePancreatitisAnti-Inflammatory Agents, Non-SteroidalPostoperative ComplicationsHumansRetrospective StudiesFemaleMaleAdministration, RectalChildAdolescentChild, PreschoolTreatment OutcomeAcute Kidney InjuryIncidenceInfant

Stichwörter der Autor:innen

complicationsendoscopynonsteroidal anti‐inflammatory drugspancreasprophylaxis

Substanzen

IndomethacinAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Health Services Research Center, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Division of Gastroenterology & Center for Digestive Health and Surgery, Atrium Health-Wake Forest University, Charlotte, North Carolina, USA.
  • Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of Medicine, Division of Digestive Diseases, Emory University, Atlanta, Georgia, USA.

ORCID-Profile: Mary C Camacho, Field F Willingham

Förderung

  • Department of Medicine at Emory University School of Medicine
  • Health Services Research Center at Emory University

Zitieren

APA

Camacho, M. C., Blythe, E., Elmunzer, B. J., Odiase, E., Gandhi, D., Fritzen, C., Cohen, R. Z., Sauer, C., & Willingham, F. F. (2026). Safety and efficacy of rectal indomethacin for prevention of post‐endoscopic retrograde cholangiopancreatography pancreatitis in pediatric patients. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70427

Vancouver

Camacho MC, Blythe E, Elmunzer BJ, Odiase E, Gandhi D, Fritzen C, et al. Safety and efficacy of rectal indomethacin for prevention of post‐endoscopic retrograde cholangiopancreatography pancreatitis in pediatric patients. Journal of Pediatric Gastroenterology and Nutrition. 2026. doi:10.1002/jpn3.70427

BibTeX
@article{Camacho2026,
  author = {Camacho, Mary C and Blythe, Emma and Elmunzer, B Joseph and Odiase, Elaine and Gandhi, Devika and Fritzen, Christopher and Cohen, Reuven Zev and Sauer, Cary and Willingham, Field F},
  title = {Safety and efficacy of rectal indomethacin for prevention of post‐endoscopic retrograde cholangiopancreatography pancreatitis in pediatric patients},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2026},
  doi = {10.1002/jpn3.70427}
}
Kostenlos starten →